XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development, net of grant reimbursement $ 16,948 $ 3,901 $ 31,854 $ 6,430
General and administrative 2,969 1,237 5,884 2,241
Total operating expenses 19,917 5,138 37,738 8,671
Operating loss (19,917) (5,138) (37,738) (8,671)
Interest income 314 13 345 20
Other income, net 275   538  
Net loss $ (19,328) $ (5,125) $ (36,855) $ (8,651)
Net Loss Per Share Basic And Diluted $ (0.48) $ (0.13) $ (0.92) $ (0.22)
Shares used in computing net loss per share, basic and diluted 40,015 39,953 39,989 38,843